series-b
Stage
1
Investors
About
Invivyd develops antibody-based therapies aimed at restoring immune function in patients with chronic viral infections and associated diseases.
Explore Invivyd's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.